A multicentre prospective cohort study assessing the effectiveness of budesonide MMX® (Cortiment®(MMX®)) for active, mild-to-moderate ulcerative colitis

BACKGROUND: Cortiment®(MMX®) (budesonide MMX®) is currently approved for the induction of remission in mild-to-moderate ulcerative colitis (UC) patients when 5-ASA treatment is not sufficient. Data in real-life settings are lacking. METHODS: This was a multicentre observational prospective cohort st...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:United European Gastroenterol J
Hlavní autoři: Danese, Silvio, Hart, Ailsa, Dignass, Axel, Fiorino, Gionata, Louis, Edouard, Bonovas, Stefanos, D'Haens, Geert, Dotan, Iris, Rogler, Gerhard, Paridaens, Kristine, Peyrin-Biroulet, Laurent
Médium: Artigo
Jazyk:Inglês
Vydáno: SAGE Publications 2019
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6826527/
https://ncbi.nlm.nih.gov/pubmed/31700630
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640619864848
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky